Name : Miss. SAIMA TREHGAM Patient UID.

: 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:21PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 08:46PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
COMPLETE BLOOD COUNT (CBC),WHOLE BLOOD EDTA
HAEMOGLOBIN (Hb) 12.3 g/dL 12.0-15.0
Methodology: colorimetric method
RED BLOOD CELLS- RBC COUNT 4.77 millions/mm³ 3.8 - 4.8
Methodology: electric impedance
PACKED CELL VOLUME (PCV) -HEMATOCRIT 40.7 % 40.0-50.0
Methodology: Pulse Height detection method
MCV 85.32 fL 83-101
Methodology: Automated/Calculated
MCH 25.79 pg 27.0-32.0
Methodology: by Automated/Calculated
MCHC 30.22 g/dL 31.5-34.5
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.4 % 11.6-14.0
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-SD) 46.6 fL 39.0- 46.0
Methodology: Automated/Calculated
MENTZER INDEX 17.89
Methodology: Calculated
PLATELET COUNT 291 10^3/µL 150-410
Methodology: Electric impedance/Microscopy
PLATELET DISTRIBUTION WIDTH (PDW) 10.2 fL 9.00-17.00
Methodology: Calculated
PCT(PLATELETCRIT) 0.260 % 0.108-0.282
Methodology: Calculated
MEAN PLATELET VOLUME - MPV 8.9 fL 7.00-12.0
Methodology: Calculated
P-LCC 56.00 % 30.0-90.0
Methodology: Calculated
TOTAL LEUKOCYTE COUNT (TLC) 9.26 10^3/µL 4.00-10.0
Methodology: electric impedance
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 65.4 % 40 - 80
Methodology: Flow cytometry/Manual
Lymphocytes 27.2 % 20 - 40
Methodology: Flow cytometry/Manual
Eosinophils 1.2 % 1.00-6.00
Methodology: Flow cytometry/Manual
Monocytes 5.9 % 2.00-10.0

Page 1 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:21PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 08:46PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600
Methodology: Flow cytometry/Manual
Basophils 0.3 % 0.00-1.00
Methodology: Flow cytometry/Manual
ABSOLUTE NEUTROPHIL COUNT 6.06 10^3/µL 2.00-7.00
Methodology: Calculated
ABSOLUTE LYMPHOCYTE COUNT 2.52 10^3/µL 1.00-3.00
ABSOLUTE EOSINOPHIL COUNT 0.11 10^3/µL 0.02-0.50
Methodology: Calculated
ABSOLUTE MONOCYTE COUNT 0.55 10^3/µL 0.20-1.00
Methodology: Calculated
ABSOLUTE BASOPHIL COUNT 0.03 10^3/µL 0.02-0.10
Methodology: Calculated
CLINICAL NOTES
A complete blood count (CBC) is used to evaluate overall health and detect wide range of disorders, including anemia, infection and [Link] have been some reports
of WBC and platelet counts being lower in venous blood than in capillary blood samples ,although still within these reference ranges.

POSSIBLE CAUSES OF ABNORMAL PARAMETERS

High RBC, Hb, or HCT - dehydration, Low RBC, Hb, or HCT - anemia,
polycythemia,shock, chronic hypoxia thalassemia, and other hemoglobinopathies.
High MCV - macrocytic anemia, liver disease Low MCV - microcytic anemia.
High WBC -acute stress,
Low WBC - sepsis, marrow hypoplasia
infection,malignancies
High platelets - risk of thrombosis Low platelets - risk of bleeding

Notes
[Link] Anemia/Dimorphic Anemia can have low platelet count.
[Link] Anemia/Leucocytosis can have Reactive thrombocytosis.

*** End Of Report ***

Page 2 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 10:54PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
LIVER FUNCTION TEST (LFT) - EXTENDED
BILIRUBIN TOTAL,Serum 0.55 mg/dL 0.10 - 1.20
Methodology: Diazonium Ion
DIRECT BILIRUBIN(CONJUGATED), Serum 0.19 mg/dl 0.00-0.20
Methodology: Diazo Method
INDIRECT BILIRUBIN,Serum 0.36 mg/dL 0.80
Methodology: Calculated
SGPT (ALT), SERUM 12.80 U/L 0-35
Methodology: UV without P5P
SGOT (AST) ,SERUM 22.20 IU/L 0.0-32.0
Methodology: UV With P5P
ALKALINE PHOSPHATASE ,Serum 92.5 U/L 53-128
Methodology: IFCC
GAMMA GLUTAMYL TRANSFERASE (GGT),Serum 12.00 U/L 12.0-58.0
Methodology: IFCC
TOTAL PROTEIN , Serum 7.6 g/dL 6.00-8.30
Methodology: Biuret
Albumin,Serum 4.27 g/dL 3.2-5.20
Methodology: BCG
GLOBULIN,SERUM 3.33 g/dL 2.30-4.50
Methodology: Calculated
A/G Ratio ,Serum 1.28 1.0 - 2.3
Methodology: Calculated
SGOT/SGPT RATIO 1.73
COMMENT
These are group of tests that can be used to detect the presence of liver disease, distinguish among different types of liver disorders, gauge the extent of known liver
damage, and monitor the response to treatment. Most liver diseases cause only mild symptoms initially, but these diseases must be detected early. Some tests are
associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase
and alkaline phosphatase). Conditions with elevated levels of ALT and AST include hepatitis A,B ,C ,paracetamol toxicity [Link] biochemical tests are useful in the
evaluation and management of patients with hepatic dysfunction. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on
those individuals taking certain medications, such as anticonvulsants, to ensure that the medications are not adversely impacting the person's liver.

Reference ranges are from Teitz fundamental of clinical chemistry 8th ed (2018)

*** End Of Report ***

Page 3 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 10:54PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
LIPID PROFILE BASIC
CHOLESTEROL TOTAL - Serum 123.60 mg/dL <200 Desirable
Methodology: Cholesterol Oxidase,Esterase,Peroxidase 200-239 Borderline high risk
>240 High risk
TRIGLYCERIDES - SERUM 148.40 mg/dL <150
Methodology: Enzymatic, end Point
CHOLESTEROL - HDL (DIRECT) 31.90 mg/dL >40 Recommended Range
Methodology: Direct measure ,polymer-polyanion
NON-HDL CHOLESTEROL 91.70 mg/dL <130
CHOLESTEROL-LDL (DIRECT) 62.02 mg/dL <130 Recommended Range
Methodology: Calculated
VLDL ,SERUM 29.68 mg/dL 0.00 - 45.0
Methodology: Calculated
CHOL/HDL Ratio 3.87 Ratio 3.40-4.40
Methodology: Calculated
LDL/HDL Ratio 1.94 Ratio 1.0-3.5
Methodology: Calculated
HDL/LDL CHOLESTEROL RATIO 0.51 Ratio <3.50
Methodology: Calculated
REFERENCE RANGES AS PER NCEP ATP III GUIDLINES

TOTAL CHOLESTEROL mg/dl HDL mg/dl LDL mg/dl TRIGLYCERIDES mg/dl

Desirable <200 Low <40 Optimal <100 Normal <150
Near Optimal 100-129
Borderline High 200-239 High >60 Borderline High 150-199
Borderline High 130-159
High 160-189 High 200-499
High >240 - -
Very High >190 Very High >500

ALERT!!! 10-12 hours fasting is mandatory for lipid [Link] not,values might fluctuate.
CLINICAL NOTES-Lipid profile is initial screening tool for abnormalities in lipids. The results of this test can identify certain genetic diseases & can determine approximate risks
for cardiovascular disease, certain forms of pancreatitis. Hypertriglyceridemia is indicative of insulin resistance when present with low HDL & elevated LDL, while elevated TG is
risk factor for coronary artery disease,especially when low HDL is [Link] of 500mg/dL or more can be concerning for development of pancreatitis.*The calculated value for
LDL-C is typically reported as part of the lipid profile as per friedewald equation. When triglycerides are high(>350mg/dl), the equation is no longer valid. In this situation,
the only way to accurately determine LDL-C is to measure it directly.

Remark-Measurements in the same patient can show physiological & analytical variations. 3 serial samples 1 week apart are recomended for Total Cholesterol, TG, HDL & LDL
[Link] per NCEP guidelines, all adults above the age of 20 years should be screened for lipid [Link] screening of children above the age of 2 years with a
family history of premature cardiovascular disease or those with at least one parent with high total cholesterol is [Link] Identifies elevated Triglycerides as an
independent risk factor for Coronary Heart Disease (CHD) .RefFriedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in
plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18;499-502. PubMed ID: 4337382)

*** End Of Report ***

Page 4 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 10:54PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
IRON PROFILE BASIC
IRON -Serum 61.19 ug/dL 59.0-158.0
Methodology: Ferrozine-no Deproteinization
UIBC-SERUM 408.38 ug/dL 110 - 370
Methodology: NiTRO-PSAP
TOTAL IRON BINDING CAPACITY 469.57 ug/dL 240-450
Methodology: Calculated
TRANSFERRIN SATURATION 13.03 % 15.0-50.0
Methodology: Calculated
CLINICAL NOTES
The serum iron test is used to measure the amount of iron that is in transit in the body – the iron that is bound to transferrin in the blood. Along with other tests, it is used to
help detect and diagnose iron deficiency or iron overload. Testing may also be used to help differentiate various causes of [Link] amount of iron present in the blood
will vary throughout the day and from day to day. For this reason, serum iron is almost always measured with other iron tests, including ferritin, transferrin, and calculated
total iron-binding capacity (TIBC) and transferrin [Link] ferritin appears to be in equilibrium with tissue ferritin and is a good indicator of storage iron in normal
subjects and in most disorders. In patients with some hepatocellular diseases, malignancies and inflammatory diseases, serum ferritin is a disproportionately high estimate of
storage iron because serum ferritin is an acute phase reactant. In such disorders iron deficiency anemia may exist with a normal serum ferritin conc. In the presence of
inflammation, persons with low serum ferritin are likely to respond to iron therapy.

Increased Levels
-Iron overload – Hemochromatosis, Thalassemia & Sideroblastic anemia
-Malignant conditions - Acute myeloblastic & Lymphoblastic leukemia, Hodgkin’s disease & Breast carcinoma
-Inflammatory diseases - Pulmonary infections, Osteomyelitis, Chronic UTI,
-Rheumatoid arthritis, SLE, burns,Acute & Chronic hepatocellular disease

Decreased Levels
-Iron deficiency anemia

*** End Of Report ***

Page 5 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 10:54PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)
CREATININE-SERUM 0.61 mg/dL 0.40-1.10
Methodology: Jaffe Kinetic
eGFR 129.55 mL/min/1.73m2 60-180
COMMENT
The Kidney Disease Improving Global Outcomes (KDIGO) guideline defines CKD by the presence of glomerular filtration rate (GFR) 3 months and/or evidence of kidney
damage (eg, structural abnormalities, histologic abnormalities, albuminuria, urinary sediment abnormalities, renal tubular disorders, and/or history of kidney transplantation)
for >3months.2 Thus, monitoring should include tests for GFR, albuminuria, and urine [Link] young adults with normal kidneys will have an eGFR as low as 75
ml/min, and this falls by about 1 ml/min per year as people get older, so many healthy people aged 75 will have an eGFR of 50-60 ml/min

CLINICAL USE
Detect chronic kidney disease (CKD) in adults.
Monitor CKD therapy and/or progression in adults.

Interpretation of eGFR Values(MDRD)

eGFR (mL/min/1.73m2) Interpretation
90-180 Normal
60-89 Mild decrease
45-59 Mild to moderate decrease
30-44 Moderate to severe decrease
15-29 Severe decrease
<15 Kidney failure

Individuals Suitable for Testing

[Link] aged 18 years and older who are at risk of or who have CKD
[Link] with diabetes, hypertension, autoimmune disease, systemic infections, and family history of kidney disease are some of those at increased risk.
[Link] test is not suitable for people with unstable creatinine concentrations such as seen in patients hospitalized with acute illness, in pregnant women, and in those with
serious co-morbid conditions.
[Link] is this test suitable for people with extremes of muscle mass, ie, amputees, paraplegics, bodybuilders, patients with muscle-wasting disease, and patients with a
neuromuscular disorder.
[Link] test is also not suitable for obese people, patients suffering from malnutrition, those with a vegetarian or low-meat diet, and those taking creatine dietary supplements

PHOSPHORUS-SERUM
PHOSPHORUS-SERUM 4.16 mg/dL 2.5 - 4.5
Methodology: Phosphomolybdate
KIDNEY FUNCTION TEST-ADVANCE-KIDNEY FUNCTION TEST (KFT)CA
UREA - SERUM 19.31 mg/dL 15.0 - 40.0
Methodology: Urease UV
CREATININE-SERUM 0.61 mg/dL 0.40-1.10
Methodology: Jaffe Kinetic
URIC ACID - SERUM 2.94 mg/dL 2.60 - 6.00
Methodology: URICASE-POD
SODIUM (SERUM) 136.46 mmol/L 135 - 150

Page 6 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 10:54PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600
Methodology: ISE
POTASSIUM-SERUM 4.28 mmol/L 3.5 - 5.5
Methodology: ISE
CHLORIDE ,Serum 99.90 mmol/L 94 - 110
Methodology: ISE
BLOOD UREA NITROGEN (BUN) 9.02 mg/dL 8.00-23.0
Methodology: Calculated
BUN/CREATININE RATIO 14.79 Ratio 10-20:1 Normal
Methodology: Calculated
UREA / CREATININE RATIO 31.66 Ratio 40-100:1 Normal
Methodology: Calculated
CALCIUM , Serum 9.28 mg/dL 8.4 - 10.6
Methodology: BAPTA
INTERPRETATION
Kidney function tests are group of tests that can be used to evaluate how well the kidneys are [Link] is a waste product produced by muscles from the
breakdown of a compound called creatine. In blood, it is a marker of GFR ,in urine, it can remove the need for 24-hour collections for many analytes or be used as a quality
assurance tool to assess the accuracy of a 24-hour collection . It is removed from the body by the kidneys, which filter almost all of it from the blood and release it into the
[Link] is part of the cycle that produces energy needed to contract muscles. Both creatine and creatinine are produced by the body at a relatively constant rate.
Since almost all creatinine is filtered from the blood by the kidneys and released into the urine, blood levels are usually a good indicator of how well the kidneys are working.

REMARK-The amount of creatinine you produce depends on your body size and your muscle mass. For this reason, creatinine levels are usually slightly higher in men than
in women and [Link] drugs are nephrotoxic hence KFT is done before and after initiation of treatment with these drugs.

Higher creatinine than normal level may be due to: • Blockage in the urinary tract • Kidney problems, such as kidney damage or failure, infection, or reduced blood
flow • Loss of body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures (eclampsia)), or high blood
pressure caused by pregnancy (preeclampsia)
Lower than normal creatinine level may be due to: • Myasthenia Gravis • Muscular [Link] serum creatinine values are rare; they almost always reflect low
muscle mass.

*** End Of Report ***

Page 7 of 8
 Name : Miss. SAIMA TREHGAM Patient UID. : 9397940
Age/Gender : 22 Yrs/Female Visit No. : 0355125071900010
Referred Client : LDPLJK2216-LDPL KUPWARA-2 Collected on : 19-Jul-2025 04:59PM
Referred By : SELF Received on : 19-Jul-2025 08:35PM
Doctor Name : Dr. SELF Reported on : 19-Jul-2025 09:49PM
Sample Type : - ,Serum - JK178601,Whole Blood EDTA - JK178600

IMMUNOLOGY
Test Name Results Unit Bio. Ref. Interval
THYROID PROFILE : T3, T4 & TSH(TFT)
TRIODOTHYRONINE TOTAL (T3),Serum 0.72 ng/mL 0.70-2.04
Methodology: ECLIA
THYROXINE TOTAL (T4),Serum 6.23 ug/dl 5.1-14.1
Methodology: ECLIA
THYROID STIMULATING HORMONE (TSH),Serum 0.534 µIU/ml 0.35-5.50
Methodology: ECLIA
NOTE-TSH levels are subject to circardian variation,reaching peak levels between 2-4 AM and min between 6-10 PM. The variation is the order of 50% hence time of the day has influence on the
measures serum TSH [Link] and time of drug intake also influence the test result.
Transient increase in TSH levels or abnormal TSH levels can be seen in some non thyroidal conditions,simoultaneous measurement of TSH with free T4 is useful in evaluating differantial diagnosis.

INTERPRETATION-Ultra Sensitive 4th generation assay

[Link] hyperthyroidism is accompanied by ↑serum T3 & T4 values along with ↓ TSH level.
[Link] TSH,high FT4 and TSH receptor antibody(TRAb) +ve seen in patients with Graves disease
[Link] TSH,high FT4 and TSH receptor antibody(TRAb) -ve seen in patients with Toxic adenoma/Toxic Multinodular goiter
[Link],Low FT4 and Thyroid microsomal antibody increased seen in patients with Hashimotos thyroiditis
[Link],Low FT4 and Thyroid microsomal antibody normal seen in patients with Iodine deficiency/Congenital T4 synthesis deficiency
[Link] TSH,Low FT4 and TRH stimulation test -Delayed response seen in patients with Tertiary hypothyroidism
[Link] hypothyroidism is accompanied by ↓ serum T3 and T4 values & ↑serum TSH levels
[Link] T4 levels accompanied by ↑ T3 levels and low TSH are seen in patients with T3 Thyrotoxicosis
[Link] or↓ T3 & ↑T4 levels indicate T4 Thyrotoxicosis ( problem is conversion of T4 to T3)
[Link] T3 & T4 along with ↓ TSH indicate mild / Subclinical Hyperthyroidism .
[Link] T3 & ↓ T4 along with ↑ TSH is seen in Hypothyroidism .
[Link] T3 & T4 levels with ↑ TSH indicate Mild / Subclinical Hypothyroidism .
[Link] ↑ T3 levels may be found in pregnancy and in estrogen therapy while ↓ levels may be encountered in severe illness , malnutrition , renal failure and during therapy with drugs like
propanolol.
[Link] ↑ TSH levels are nearly always indicative of Primary Hypothroidism ,rarely they can result from TSH secreting pituitary tumours.

DURING PREGNANCY - REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association)
1st Trimester : 0.10-2.50 uIU/mL
2nd Trimester : 0.20-3.00 uIU/mL
3rd Trimester : 0.30-3.00 uIU/mL
The production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.

REMARK-Assay results should be interpreted in context to the clinical condition and associated results of other investigations. Previous treatment with corticosteroid therapy may result in lower TSH
levels while thyroid hormone levels are normal. Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. Abnormal thyroid test findings often found in
critically ill patients should be repeated after the critical nature of the condition is [Link] is an important marker for the diagnosis of thyroid [Link] studies have shown that the
TSH distribution progressively shifts to a higher concentration with age ,and it is debatable whether this is due to a real change with age or an increasing proportion of unrecognized thyroid disease in
the elderly.

*** End Of Report ***

Page 8 of 8